Benzinga | Feb 23, 2021 04:27PM EST

Cantor Fitzgerald Reiterates Overweight on Anavex Life Sciences, Raises Price Target to $25

Cantor Fitzgerald reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Overweight and raises the price target from $10 to $25.